OneDigital Investment Advisors LLC bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,484 shares of the company’s stock, valued at approximately $590,000.
Several other hedge funds have also bought and sold shares of CAH. Investors Research Corp purchased a new position in shares of Cardinal Health during the 2nd quarter valued at about $29,000. University of Texas Texas AM Investment Management Co. purchased a new stake in Cardinal Health in the 4th quarter worth approximately $26,000. Allied Private Wealth LLC bought a new stake in Cardinal Health during the 2nd quarter worth approximately $30,000. Bank of Jackson Hole Trust purchased a new position in Cardinal Health during the fourth quarter valued at approximately $27,000. Finally, Indiana Trust & Investment Management Co purchased a new position in Cardinal Health during the first quarter valued at approximately $29,000. Institutional investors own 87.17% of the company’s stock.
Cardinal Health Stock Performance
CAH stock opened at $234.85 on Wednesday. The company’s fifty day moving average price is $231.38 and its 200-day moving average price is $217.51. Cardinal Health, Inc. has a one year low of $145.87 and a one year high of $258.30. The company has a market capitalization of $54.62 billion, a PE ratio of 32.48, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49.
Cardinal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 28.49%.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the stock. Mizuho increased their price objective on shares of Cardinal Health from $240.00 to $250.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 12th. Bank of America lifted their target price on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Royal Bank Of Canada assumed coverage on Cardinal Health in a research note on Wednesday. They issued an “outperform” rating for the company. Weiss Ratings raised Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a report on Wednesday, August 5th. Finally, Citigroup boosted their price objective on Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Sixteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $265.93.
Check Out Our Latest Stock Analysis on CAH
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Stories
- Five stocks we like better than Cardinal Health
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
